Stocks Overview

LAST PRICE
43.2600
TODAY'S CHANGE (%)
Trending Up0.6200 (1.4540%)

Bid / Lots
42.7700/ 1
Ask / Lots
43.9100/ 1
Open / Previous Close
42.5700 / 42.6400
Day Range
Low 42.5300
High 43.3200
52 Week Range
Low 35.8144
High 49.1753
Volume
970,940
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 42.64
Time	Volume	QGEN
09:32 ET	15654	42.62
09:34 ET	1203	42.58
09:36 ET	2741	42.7
09:38 ET	1176	42.79
09:39 ET	100	42.8
09:41 ET	711	42.82
09:43 ET	1977	42.8799
09:45 ET	300	42.83
09:48 ET	727	42.77
09:50 ET	758	42.75
09:52 ET	664	42.7
09:54 ET	900	42.73
09:56 ET	1400	42.74
09:57 ET	1202	42.75
09:59 ET	806	42.74
10:01 ET	1276	42.74
10:03 ET	515	42.75
10:06 ET	607	42.75
10:08 ET	100	42.74
10:10 ET	503	42.77
10:12 ET	450	42.77
10:14 ET	505	42.77
10:15 ET	1201	42.79
10:17 ET	1343	42.8
10:19 ET	203	42.83
10:21 ET	732	42.86
10:24 ET	101	42.89
10:26 ET	4065	42.86
10:28 ET	1609	42.86
10:30 ET	300	42.86
10:32 ET	735	42.78
10:33 ET	2036	42.745
10:35 ET	557	42.75
10:37 ET	742	42.75
10:39 ET	3376	42.795
10:42 ET	5291	42.76
10:44 ET	6338	42.735
10:46 ET	4111	42.73
10:48 ET	1672	42.74
10:50 ET	2482	42.73
10:51 ET	1301	42.72
10:53 ET	4261	42.72
10:55 ET	5307	42.76
10:57 ET	1449	42.81
11:00 ET	2111	42.79
11:02 ET	631	42.79
11:04 ET	1611	42.8
11:06 ET	555	42.8
11:08 ET	649	42.8
11:09 ET	349	42.8
11:11 ET	334	42.82
11:13 ET	449	42.84
11:15 ET	1613	42.82
11:18 ET	1413	42.82
11:20 ET	706	42.82
11:22 ET	300	42.81
11:24 ET	200	42.82
11:26 ET	501	42.84
11:27 ET	400	42.84
11:29 ET	500	42.84
11:31 ET	4094	42.77
11:33 ET	15277	42.75
11:36 ET	2500	42.71
11:38 ET	276	42.74
11:40 ET	502	42.73
11:42 ET	200	42.7
11:45 ET	422	42.685
11:47 ET	950	42.69
11:49 ET	715	42.7
11:51 ET	100	42.7
11:56 ET	999	42.68
11:58 ET	700	42.67
12:00 ET	620	42.68
12:02 ET	3144	42.65
12:03 ET	211	42.645
12:07 ET	738	42.66
12:09 ET	200	42.68
12:12 ET	535	42.66
12:14 ET	200	42.67
12:16 ET	200	42.68
12:18 ET	1440	42.6673
12:20 ET	435	42.67
12:21 ET	100	42.68
12:23 ET	259	42.66
12:25 ET	2766	42.68
12:27 ET	545	42.66
12:30 ET	100	42.66
12:32 ET	1127	42.63
12:36 ET	600	42.64
12:38 ET	562	42.635
12:39 ET	300	42.64
12:41 ET	564	42.65
12:45 ET	100	42.65
12:48 ET	936	42.64
12:50 ET	100	42.64
12:52 ET	918	42.64
12:54 ET	259	42.64
12:56 ET	200	42.64
01:01 ET	100	42.645
01:03 ET	516	42.64
01:06 ET	600	42.62
01:08 ET	100	42.62
01:10 ET	200	42.615
01:12 ET	534	42.62
01:14 ET	100	42.615
01:15 ET	1036	42.63
01:17 ET	203	42.64
01:19 ET	202	42.6399
01:21 ET	532	42.65
01:24 ET	400	42.66
01:26 ET	300	42.67
01:28 ET	202	42.68
01:30 ET	100	42.67
01:32 ET	100	42.67
01:33 ET	688	42.67
01:35 ET	300	42.68
01:39 ET	1095	42.65
01:42 ET	100	42.65
01:44 ET	100	42.645
01:46 ET	723	42.67
01:48 ET	100	42.65
01:53 ET	400	42.645
01:55 ET	900	42.64
01:57 ET	600	42.65
02:00 ET	420	42.65
02:02 ET	506	42.65
02:04 ET	400	42.65
02:06 ET	340	42.66
02:08 ET	1673	42.67
02:09 ET	2653	42.69
02:11 ET	1572	42.7
02:13 ET	200	42.71
02:15 ET	1275	42.71
02:18 ET	412	42.74
02:20 ET	1000	42.75
02:22 ET	765	42.75
02:24 ET	1855	42.74
02:26 ET	100	42.75
02:27 ET	1200	42.74
02:29 ET	1611	42.74
02:31 ET	452	42.745
02:33 ET	800	42.77
02:36 ET	967	42.78
02:38 ET	1760	42.79
02:40 ET	200	42.8
02:42 ET	769	42.8
02:44 ET	534	42.82
02:45 ET	1414	42.815
02:47 ET	3710	42.81
02:49 ET	400	42.8
02:51 ET	400	42.8
02:54 ET	1125	42.83
02:56 ET	2157	42.85
02:58 ET	5702	42.85
03:00 ET	400	42.84
03:02 ET	4817	42.88
03:03 ET	2320	42.89
03:05 ET	2016	42.885
03:07 ET	2993	42.89
03:09 ET	3892	42.91
03:12 ET	3082	42.91
03:14 ET	1464	42.92
03:16 ET	2866	42.95
03:18 ET	4082	42.94
03:20 ET	3326	42.94
03:21 ET	3434	42.94
03:23 ET	3122	42.97
03:25 ET	1800	43
03:27 ET	5585	43.01
03:30 ET	2429	43.01
03:32 ET	4560	42.99
03:34 ET	4437	43
03:36 ET	3320	43.01
03:38 ET	4778	43.02
03:39 ET	2966	43.035
03:41 ET	7565	43.11
03:43 ET	5841	43.15
03:45 ET	14611	43.21
03:48 ET	10408	43.205
03:50 ET	11330	43.21
03:52 ET	9928	43.195
03:54 ET	18246	43.2
03:56 ET	12710	43.23
03:57 ET	23639	43.285
03:59 ET	36776	43.26

Data delayed at least 15 minutes.

Yesterday
- QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications, from 5:55PM ET on Thursday May 30, 2024 by Dow Jones
  5:55PM ET on Thursday May 30, 2024 by Dow Jones
- QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications, from 4:05PM ET on Thursday May 30, 2024 by Dow Jones
  4:05PM ET on Thursday May 30, 2024 by Dow Jones
May 29, 2024
- QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine, from 4:05PM ET on Wednesday May 29, 2024 by Dow Jones
  4:05PM ET on Wednesday May 29, 2024 by Dow Jones
May 14, 2024
- QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support, from 4:05PM ET on Tuesday May 14, 2024 by Dow Jones
  4:05PM ET on Tuesday May 14, 2024 by Dow Jones
May 13, 2024
- QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results, from 2:00AM ET on Monday May 13, 2024 by Dow Jones
  2:00AM ET on Monday May 13, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesQGEN Qiagen NV	9.5B	28.4x	+12.66%
United StatesMEDP Medpace Holdings Inc	12.0B	39.4x	+35.10%
United StatesEXEL Exelixis Inc	6.1B	33.5x	-21.77%
United StatesEXAS Exact Sciences Corp	8.3B	-34.3x	---
United StatesNBIX Neurocrine Biosciences Inc	13.8B	37.2x	+62.04%
United StatesUTHR United Therapeutics Corp	12.0B	13.0x	+8.22%
As of 2024-05-31

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Contact Information

Headquarters: Hulsterweg 82VENLO, Netherlands 5912 PL
Phone: ---
Fax: ---

Executives

Independent Chairman of the Supervisory Board: Lawrence Rosen
Chief Executive Officer, Managing Director, Member of the Executive Board: Thierry Bernard
Managing Director, Chief Financial Officer, Member of the Executive Board: Roland Sackers
Independent Member of the Supervisory Board: Metin Colpan
Independent Member of the Supervisory Board: Toralf Haag

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$9.5B
Revenue (TTM)	$2.0B
Shares Outstanding	221.8M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.42
EPS	$1.53
Book Value	$17.20
P/E Ratio	28.4x
Price/Sales (TTM)	4.8
Price/Cash Flow (TTM)	17.3x
Operating Margin	20.69%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Qiagen NV
NYSE:QGENUnited States

Search Criteria

Charts

Recent News

Yesterday

QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications, from 5:55PM ET on Thursday May 30, 2024 by Dow Jones

QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications, from 4:05PM ET on Thursday May 30, 2024 by Dow Jones

May 29, 2024

QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine, from 4:05PM ET on Wednesday May 29, 2024 by Dow Jones

May 14, 2024

QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support, from 4:05PM ET on Tuesday May 14, 2024 by Dow Jones

May 13, 2024

QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results, from 2:00AM ET on Monday May 13, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar